Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Calverley

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activityYoshitomo Suhara, Atsushi Kittaka, Seishi Kishimoto, et al.
Endocrinology|December 6, 1997
The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activityF J Dilworth, G R Williams, A M Kissmeyer, et al.
The Journal of Biological Chemistry|July 14, 1995
Different mechanisms of hydroxylation site selection by liver and kidney cytochrome P450 species (CYP27 and CYP24) involved in vitamin D metabolismF J Dilworth, I Scott, A Green, et al.
Biochemical Pharmacology|March 21, 1997
Metabolism of the vitamin D analog EB1089 by cultured human cells: redirection of hydroxylation site to distal carbons of the side-chainV N Shankar, F J Dilworth, H L Makin, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activityYoshitomo Suhara, Atsushi Kittaka, Seishi Kishimoto, et al.
Endocrinology|December 6, 1997
The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activityF J Dilworth, G R Williams, A M Kissmeyer, et al.
The Journal of Biological Chemistry|July 14, 1995
Different mechanisms of hydroxylation site selection by liver and kidney cytochrome P450 species (CYP27 and CYP24) involved in vitamin D metabolismF J Dilworth, I Scott, A Green, et al.
Biochemical Pharmacology|March 21, 1997
Metabolism of the vitamin D analog EB1089 by cultured human cells: redirection of hydroxylation site to distal carbons of the side-chainV N Shankar, F J Dilworth, H L Makin, et al.
Pageof 4